We provide the first evidence that feimin expression is elevated in microglia in an HFD model and negatively regulates LD accumulation and inflammation by suppressing the AKT–mTOR pathway, correspondingly alleviating cognitive impairment in the in vivo HFD model. The gene discussed is MTOR; the disease is Cognitive impairment.